Morning Overview on MSN
An SGLT2 pill protected the kidneys of teenagers with type 1 diabetes in a new trial
Teenagers with type 1 diabetes now have the first randomized trial evidence that an SGLT2 inhibitor can protect their kidneys ...
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology. The study ...
Two classes of diabetes drugs show health benefits far beyond improving blood sugar. When used together, their effects are even more evident. For individuals with type 2 diabetes, SGLT2 inhibitors ...
If you have IgA nephropathy (IgAN), youve likely heard about the importance of protecting your kidneys and slowing down the disease. In IgAN, immunoglobulin A (IgA) antibodies accumulate in the ...
When it comes to kidney and cardiovascular outcomes, there is no significant difference between treatment with an SGLT2 inhibitor or GLP-1 receptor agonist in patients with type 2 diabetes, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results